This inventor holds 3 USPTO granted patents and 1 published patent application. Top assignee: University of South Florida. Active years: 2010-2011.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2010-2011
Title: Innovations by Lia Elena Perez
Introduction
Lia Elena Perez is an accomplished inventor based in Tampa, Florida. She has made significant contributions to the field of medical research, particularly in the area of megakaryocyte and platelet production. With a total of 3 patents to her name, her work has the potential to impact blood clotting therapies.
Latest Patents
One of her latest patents is titled "SHIP-deficiency to increase megakaryocyte progenitor production." This invention focuses on a method for increasing megakaryocyte and megakaryocyte progenitor numbers in vitro or in vivo by suppressing SH2-containing inositol-5-phosphatase (SHIP) function. The method involves administering an interfering RNA or other SHIP inhibitors to megakaryocytes or megakaryocyte progenitors. Another notable patent is also titled "SHIP-deficiency to increase megakaryocyte progenitor production," which describes a method of increasing megakaryocytes and platelet numbers in a patient by inhibiting SHIP expression. This process aims to induce normal blood clotting.
Career Highlights
Lia Elena Perez is affiliated with the University of South Florida, where she conducts her research and develops her innovative solutions. Her work is recognized for its potential to advance medical treatments and improve patient outcomes.
Collaborations
Lia has collaborated with notable colleagues such as William Garrow Kerr and Caroline Desponts, contributing to a dynamic research environment that fosters innovation.
Conclusion
Lia Elena Perez is a pioneering inventor whose work in megakaryocyte and platelet production is paving the way for advancements in medical therapies. Her contributions are significant and hold promise for future developments in the field.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
